{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:38:49Z","timestamp":1768340329781,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Centre for Vector Borne Diseases Control"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to evaluate mass drug administration (MDA) coverage for lymphatic filariasis (LF) in selected endemic districts of Jharkhand, India, and to identify household-level determinants of drug consumption.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross-sectional coverage evaluation survey was conducted in the Deoghar, Giridih and Godda districts of Jharkhand in 2023 within 6 wk of the completion of the MDA campaign. The survey included 9039 individuals from 1680 households across 56 randomly selected clusters (three urban, eight tribal and 45 rural).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Approximately 78.5% of households reported that at least one member consumed MDA drugs, with 54.5% reaching \u2018complete epidemiological drug coverage\u2019. Factors positively associated with achieving \u2018complete epidemiological drug coverage\u2019 included higher education levels (adjusted OR [AOR] 1.02), awareness of LF (AOR 2.32), prior communication about MDA (AOR 1.38) and previous MDA participation (AOR 4.42). By contrast, larger family sizes were associated with a lower likelihood of achieving complete coverage (AOR 0.78). Adverse events were experienced by 14.9% of participants, primarily when MDA drugs were consumed on an empty stomach. Key reasons for non-compliance included perceived absence of disease (25.5%), fear of side effects (22.4%) and absence during the campaign (20.9%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>MDA coverage was suboptimal, with only one-half of households achieving \u2018complete epidemiological drug coverage\u2019. Enhancing MDA coverage and compliance requires intensified Information, Education, and Communication efforts, especially among marginalized communities, both during campaigns and all year round.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/trstmh\/trae136","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:21:32Z","timestamp":1735291292000},"page":"498-505","source":"Crossref","is-referenced-by-count":2,"title":["Mass drug administration coverage evaluation for lymphatic filariasis in selected endemic districts of Jharkhand, India"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-6446","authenticated-orcid":false,"given":"Bijit","family":"Biswas","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences Department of Community & Family Medicine, , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Gupta","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Microbiology, , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Jahnavi","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of Community & Family Medicine, , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishit","family":"Ranjan","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of General Surgery, , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya Ranjan","family":"Patra","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Department of General Surgery, , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Varshney","sequence":"additional","affiliation":[{"name":"Executive Director & Chief Executive Officer, All India Institute of Medical Sciences , Deoghar, Jharkhand ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"2025050501564605000_bib1"},{"issue":"5","key":"2025050501564605000_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/trstmh\/trac119","article-title":"Knowledge and participation in mass drug administration against lymphatic filariasis and soil-transmitted helminth infections among the community members in Dar es Salaam, Tanzania","volume":"117","author":"Ngunyali","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"2025050501564605000_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4103\/0972-9062.374034","article-title":"Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India","volume":"60","author":"Bashar","year":"2023","journal-title":"J Vector Borne Dis"},{"key":"2025050501564605000_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k5198","article-title":"Elimination of lymphatic filariasis in South East Asia","author":"Specht","year":"2019"},{"key":"2025050501564605000_bib5"},{"key":"2025050501564605000_bib6","doi-asserted-by":"crossref","article-title":"Empowering lymphatic filariasis affected individuals in India: acknowledging disability status and ensuring justice","author":"Joy","DOI":"10.1016\/j.lansea.2024.100400"},{"key":"2025050501564605000_bib7","author":"List of Statewise LF Endemic Districts [Internet]"},{"issue":"10","key":"2025050501564605000_bib8","doi-asserted-by":"crossref","first-page":"e0292723","DOI":"10.1371\/journal.pone.0292723","article-title":"Burden of dengue, leishmaniasis and lymphatic filariasis in India and its states from 1990-2019: analysis from the Global Burden of Disease study (GBD 2019)","volume":"18","author":"Dutta","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"2025050501564605000_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/ijph.ijph_1030_23","article-title":"Eliminating lymphatic filariasis: India's bold plan to finish 3 years ahead of global schedule","volume":"67","author":"Pati","year":"2023","journal-title":"Indian J Public Health"},{"key":"2025050501564605000_bib10"},{"key":"2025050501564605000_bib11","article-title":"National Centre for Vector Borne Diseases Control, Ministry of Health & Family Welfare, Government of India","author":"Accelerated Plan for Elimination of Lymphatic Filariasis [Internet]","year":"2018"},{"issue":"9","key":"2025050501564605000_bib12","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4103\/jfmpc.jfmpc_503_19","article-title":"Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: a mixed method study","volume":"8","author":"Banerjee","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"2025050501564605000_bib13","article-title":"Ministry of Health & Family Welfare launches nationwide Sarva Dawa Sevan or Mass Drug Administration (MDA) campaign to eliminate lymphatic filariasis (LF) [Internet]"},{"issue":"1","key":"2025050501564605000_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.24321\/0019.5138.202424","article-title":"Community perception for mass drug administration towards elimination of lymphatic filariasis: a study in Jharkhand","volume":"56","author":"Singh","year":"2024","journal-title":"JCD"},{"issue":"1","key":"2025050501564605000_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/jfmpc.jfmpc_1149_22","article-title":"Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India","volume":"12","author":"Kumar","year":"2023","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"2025050501564605000_bib16","first-page":"9","article-title":"Trend of MDA coverage and compliance in the four endemic districts of Jharkhand: a secondary data analysis","volume":"5","author":"Haider","year":"2014","journal-title":"Healthline"},{"key":"2025050501564605000_bib17"},{"key":"2025050501564605000_bib18"},{"key":"2025050501564605000_bib19"},{"key":"2025050501564605000_bib20"},{"key":"2025050501564605000_bib21"},{"key":"2025050501564605000_bib22","doi-asserted-by":"crossref","article-title":"Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination","author":"Alexander","DOI":"10.1093\/trstmh\/tru204"},{"key":"2025050501564605000_bib23","year":"2017"},{"key":"2025050501564605000_bib24"},{"issue":"1","key":"2025050501564605000_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-9957-3-31","article-title":"Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance","volume":"3","author":"Hussain","year":"2014","journal-title":"Infect Dis Poverty"},{"key":"2025050501564605000_bib26","doi-asserted-by":"publisher","DOI":"10.4103\/JVBD.JVBD_67_24","article-title":"Outcome assessment of the implementation of Mass Drug Administration against Lymphatic Filariasis, in Kalaburagi (Gulbarga) District of Karnataka state: a cross sectional Survey","author":"Babu","year":"2024","journal-title":"J Vector Borne Dis"},{"issue":"1","key":"2025050501564605000_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cegh.2019.04.013","article-title":"Mass drug administration programme against lymphatic filariasis-an evaluation of coverage and compliance in a northern Karnataka district, India","volume":"8","author":"Kulkarni","year":"2020","journal-title":"Clin Epidemiol Glob Health"},{"issue":"6","key":"2025050501564605000_bib28","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2105\/AJPH.2012.300993","article-title":"Education: a missed opportunity for public health intervention","volume":"103","author":"Cohen","year":"2013","journal-title":"Am J Public Health"},{"key":"2025050501564605000_bib29","doi-asserted-by":"crossref","first-page":"1297954","DOI":"10.3389\/fphar.2024.1297954","article-title":"Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India","volume":"15","author":"Ratna","year":"2024","journal-title":"Front Pharmacol"},{"issue":"11","key":"2025050501564605000_bib30","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2025050501564605000_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14737167.2020.1835474","article-title":"The value of communicating with patients in their first language","volume":"20","author":"Ranjan","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"2025050501564605000_bib32","doi-asserted-by":"crossref","first-page":"e0009069","DOI":"10.1371\/journal.pntd.0009069","article-title":"An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India","volume":"15","author":"Jambulingam","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2025050501564605000_bib33","doi-asserted-by":"crossref","first-page":"e0227083","DOI":"10.1371\/journal.pone.0227083","article-title":"Prevalence, risk factors and health seeking behaviour of pulmonary tuberculosis in four tribal dominated districts of Odisha: comparison with studies in other regions of India","volume":"15","author":"Hussain","year":"2020","journal-title":"PLoS One"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/5\/498\/61283600\/trae136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/5\/498\/61283600\/trae136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:57:13Z","timestamp":1746424633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/119\/5\/498\/7933524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,27]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trae136","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,27]]}}}